Placebo-controlled trial assessing the use of oral midazolam as a premedication to conscious sedation for pediatric endoscopy

C. A. Liacouras, M. Mascarenhas, C. Poon, William Wenner

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Background: This study was performed to evaluate the effect of midazolam, as premedication before intravenous conscious sedation, on preprocedural, procedural, and post-procedural patient comfort and anxiety in children undergoing endoscopy. Methods: A placebo-controlled, double-blind, randomized study was conducted in 123 children (age 7.75 ± 4.46 years, 56% male) using oral midazolam (0.5 mg/kg, maximum 20 mg) as a premedication before insertion of an intravenous access device (IV) and upper endoscopy. Patients were evaluated with regard to changes in vital signs, level of sedation during IV placement, level of pre- and post-procedure conscious sedation, ease of separation from parents, ease and duration of procedure, recovery time, and amnesia to objects shown before IV placement and immediately before the start of the procedure. Results: A significant difference was noted in the study group for the following parameters: level of sedation for IV placement (p < 0.0001), pre-procedural sedation (p < 0.001), ease of IV insertion (p < 0.003), ease of separation from parents (p = 0.022), and ease of the nursing personnel's ability to monitor the patient during the procedure (p = 0.0012). The patient's amnesia to an object shown immediately before beginning the endoscopy was increased (p < 0.001). Patients and parents were also more satisfied with the procedure process (p < 0.05). No significant difference was noted with regard to the length or performance of the procedure or recovery time or in the dose of IV medication required for successful completion of the endoscopy. Conclusion: Oral midazolam is an effective and safe premedication for children undergoing upper endoscopy and should be used in all anxious children and in patients previously judged to be difficult to sedate.

Original languageEnglish (US)
Pages (from-to)455-460
Number of pages6
JournalGastrointestinal Endoscopy
Volume47
Issue number6
DOIs
StatePublished - Jan 1 1998

Fingerprint

Conscious Sedation
Premedication
Midazolam
Endoscopy
Placebos
Pediatrics
Amnesia
Parents
Aptitude
Vital Signs
Double-Blind Method
Anxiety
Nurses
Equipment and Supplies

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Gastroenterology

Cite this

@article{9168f7a7ca9b4536b0a396881dfbc645,
title = "Placebo-controlled trial assessing the use of oral midazolam as a premedication to conscious sedation for pediatric endoscopy",
abstract = "Background: This study was performed to evaluate the effect of midazolam, as premedication before intravenous conscious sedation, on preprocedural, procedural, and post-procedural patient comfort and anxiety in children undergoing endoscopy. Methods: A placebo-controlled, double-blind, randomized study was conducted in 123 children (age 7.75 ± 4.46 years, 56{\%} male) using oral midazolam (0.5 mg/kg, maximum 20 mg) as a premedication before insertion of an intravenous access device (IV) and upper endoscopy. Patients were evaluated with regard to changes in vital signs, level of sedation during IV placement, level of pre- and post-procedure conscious sedation, ease of separation from parents, ease and duration of procedure, recovery time, and amnesia to objects shown before IV placement and immediately before the start of the procedure. Results: A significant difference was noted in the study group for the following parameters: level of sedation for IV placement (p < 0.0001), pre-procedural sedation (p < 0.001), ease of IV insertion (p < 0.003), ease of separation from parents (p = 0.022), and ease of the nursing personnel's ability to monitor the patient during the procedure (p = 0.0012). The patient's amnesia to an object shown immediately before beginning the endoscopy was increased (p < 0.001). Patients and parents were also more satisfied with the procedure process (p < 0.05). No significant difference was noted with regard to the length or performance of the procedure or recovery time or in the dose of IV medication required for successful completion of the endoscopy. Conclusion: Oral midazolam is an effective and safe premedication for children undergoing upper endoscopy and should be used in all anxious children and in patients previously judged to be difficult to sedate.",
author = "Liacouras, {C. A.} and M. Mascarenhas and C. Poon and William Wenner",
year = "1998",
month = "1",
day = "1",
doi = "10.1016/S0016-5107(98)70244-5",
language = "English (US)",
volume = "47",
pages = "455--460",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "6",

}

Placebo-controlled trial assessing the use of oral midazolam as a premedication to conscious sedation for pediatric endoscopy. / Liacouras, C. A.; Mascarenhas, M.; Poon, C.; Wenner, William.

In: Gastrointestinal Endoscopy, Vol. 47, No. 6, 01.01.1998, p. 455-460.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Placebo-controlled trial assessing the use of oral midazolam as a premedication to conscious sedation for pediatric endoscopy

AU - Liacouras, C. A.

AU - Mascarenhas, M.

AU - Poon, C.

AU - Wenner, William

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Background: This study was performed to evaluate the effect of midazolam, as premedication before intravenous conscious sedation, on preprocedural, procedural, and post-procedural patient comfort and anxiety in children undergoing endoscopy. Methods: A placebo-controlled, double-blind, randomized study was conducted in 123 children (age 7.75 ± 4.46 years, 56% male) using oral midazolam (0.5 mg/kg, maximum 20 mg) as a premedication before insertion of an intravenous access device (IV) and upper endoscopy. Patients were evaluated with regard to changes in vital signs, level of sedation during IV placement, level of pre- and post-procedure conscious sedation, ease of separation from parents, ease and duration of procedure, recovery time, and amnesia to objects shown before IV placement and immediately before the start of the procedure. Results: A significant difference was noted in the study group for the following parameters: level of sedation for IV placement (p < 0.0001), pre-procedural sedation (p < 0.001), ease of IV insertion (p < 0.003), ease of separation from parents (p = 0.022), and ease of the nursing personnel's ability to monitor the patient during the procedure (p = 0.0012). The patient's amnesia to an object shown immediately before beginning the endoscopy was increased (p < 0.001). Patients and parents were also more satisfied with the procedure process (p < 0.05). No significant difference was noted with regard to the length or performance of the procedure or recovery time or in the dose of IV medication required for successful completion of the endoscopy. Conclusion: Oral midazolam is an effective and safe premedication for children undergoing upper endoscopy and should be used in all anxious children and in patients previously judged to be difficult to sedate.

AB - Background: This study was performed to evaluate the effect of midazolam, as premedication before intravenous conscious sedation, on preprocedural, procedural, and post-procedural patient comfort and anxiety in children undergoing endoscopy. Methods: A placebo-controlled, double-blind, randomized study was conducted in 123 children (age 7.75 ± 4.46 years, 56% male) using oral midazolam (0.5 mg/kg, maximum 20 mg) as a premedication before insertion of an intravenous access device (IV) and upper endoscopy. Patients were evaluated with regard to changes in vital signs, level of sedation during IV placement, level of pre- and post-procedure conscious sedation, ease of separation from parents, ease and duration of procedure, recovery time, and amnesia to objects shown before IV placement and immediately before the start of the procedure. Results: A significant difference was noted in the study group for the following parameters: level of sedation for IV placement (p < 0.0001), pre-procedural sedation (p < 0.001), ease of IV insertion (p < 0.003), ease of separation from parents (p = 0.022), and ease of the nursing personnel's ability to monitor the patient during the procedure (p = 0.0012). The patient's amnesia to an object shown immediately before beginning the endoscopy was increased (p < 0.001). Patients and parents were also more satisfied with the procedure process (p < 0.05). No significant difference was noted with regard to the length or performance of the procedure or recovery time or in the dose of IV medication required for successful completion of the endoscopy. Conclusion: Oral midazolam is an effective and safe premedication for children undergoing upper endoscopy and should be used in all anxious children and in patients previously judged to be difficult to sedate.

UR - http://www.scopus.com/inward/record.url?scp=0031807198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031807198&partnerID=8YFLogxK

U2 - 10.1016/S0016-5107(98)70244-5

DO - 10.1016/S0016-5107(98)70244-5

M3 - Article

C2 - 9647368

AN - SCOPUS:0031807198

VL - 47

SP - 455

EP - 460

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 6

ER -